{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:50:12Z","timestamp":1792443012095,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019637","name":"Horizon Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","canadianjournalofophthalmology.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jcjo.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:19:01Z","timestamp":1721827141000},"page":"e59-e64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Orbital decompression following treatment with teprotumumab for thyroid eye disease"],"prefix":"10.1016","volume":"60","author":[{"given":"Nicole J.","family":"Topilow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-569X","authenticated-orcid":false,"given":"Rafaella Cleto","family":"Penteado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8127-2574","authenticated-orcid":false,"given":"Eman","family":"Al-Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Villatoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Sook","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby S.","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don O.","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2024.06.003_bib0001","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0002","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0003","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41433-021-01593-z","article-title":"Teprotumumab for the treatment of chronic thyroid eye disease","volume":"36","author":"Ugradar","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0004","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/01676830.2021.1933081","article-title":"Teprotumumab for chronic thyroid eye disease","volume":"41","author":"Ozzello","year":"2022","journal-title":"Orbit"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0005","article-title":"Early experience with teprotumumab for chronic thyroid eye disease","volume":"19","author":"Ozzello","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0006","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1097\/IOP.0000000000001119","article-title":"Orbital decompression for thyroid-related orbitopathy during the quiescent phase","volume":"34","author":"Ediriwickrema","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0007","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/eye.2017.260","article-title":"Orbital decompression for thyroid eye disease: methods, outcomes, and complications","volume":"32","author":"Jefferis","year":"2018","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3537675","article-title":"Strategies in surgical decompression for thyroid eye disease","volume":"2020","author":"Cheng","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0009","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/00005537-200307000-00017","article-title":"Medial and lateral orbital wall surgery for balanced decompression in thyroid eye disease","volume":"113","author":"Graham","year":"2003","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.otohns.2005.02.006","article-title":"Orbital decompression in graves' ophthalmopathy by medial and lateral wall removal","volume":"133","author":"Sellari-Franceschini","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0011","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bjo.2008.149302","article-title":"Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures","volume":"93","author":"Mourits","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0012","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bjophthalmol-2020-316051","article-title":"Medical treatment in thyroid eye disease in 2020","volume":"105","author":"Khong","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0189","article-title":"Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association","volume":"11","author":"Burch","year":"2022","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0015","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0016","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/01676830.2022.2122515","article-title":"Differential effects of teprotumumab treatment based on fat-to-muscle ratio in patients with thyroid eye disease","volume":"42","author":"Ting","year":"2023","journal-title":"Orbit"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0017","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/01676830.2023.2282509","article-title":"A comparison of proptosis reduction with teprotumumab versus surgical decompression based on fat-to-muscle ratio in thyroid eye disease","volume":"43","author":"Ting","year":"2024","journal-title":"Orbit"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0018","article-title":"Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study","volume":"23","author":"Sears","year":"2021","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.jcjo.2024.06.003_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jamaophthalmol.2020.5296","article-title":"Teprotumumab for optic neuropathy in thyroid eye disease","volume":"139","author":"Slentz","year":"2021","journal-title":"JAMA Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224001741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224001741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:24:24Z","timestamp":1737681864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418224001741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0008418224001741"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.06.003","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orbital decompression following treatment with teprotumumab for thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Canadian Ophthalmological Society.","name":"copyright","label":"Copyright"}]}}